On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

NewYork–Presbyterian Hospital

InstitutionResearch output, impact & collaborations

NewYork–Presbyterian Hospital is a institution indexed in ScholarIQ from OpenAlex.

What is known about NewYork–Presbyterian Hospital?

ScholarIQrecord summary

NewYork–Presbyterian Hospital is a research organisation in New York, US. OpenAlex records 51,726 works and 6,763,601 citations for it. 8,874 researchers list it as their most recent affiliation.

How many works does NewYork–Presbyterian Hospital have?

ScholarIQindexed works

NewYork–Presbyterian Hospital has 51,726 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for NewYork–Presbyterian Hospital →

How many citations does NewYork–Presbyterian Hospital have?

ScholarIQcitation count

NewYork–Presbyterian Hospital has 6,763,601 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for NewYork–Presbyterian Hospital →

How many researchers are at NewYork–Presbyterian Hospital?

ScholarIQresearcher count

NewYork–Presbyterian Hospital has 8,874 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at NewYork–Presbyterian Hospital?

ScholarIQavg h-index

NewYork–Presbyterian Hospital has an average h-index of 78.1 in OpenAlex.

Open the OpenAlex record →

What is the ROR of NewYork–Presbyterian Hospital?

ScholarIQror

The ROR for NewYork–Presbyterian Hospital is on the source record.

Open the ROR →

What is the OpenAlex record for NewYork–Presbyterian Hospital?

ScholarIQopenalex

The OpenAlex for NewYork–Presbyterian Hospital is on the source record.

Open the OpenAlex →

What is the Wikidata of NewYork–Presbyterian Hospital?

ScholarIQwikidata

The Wikidata for NewYork–Presbyterian Hospital is on the source record.

Open the Wikidata →

Who are the most-cited researchers behind NewYork–Presbyterian Hospital?

ScholarIQtop researchers by citations

David J. Cohen · Cardiac Valve Diseases and Treatments

1,148 works79,397 citations

William M. Gardner · Archaeology and Natural History

196 works76,887 citations

Jeffrey W. Moses · Coronary Interventions and Diagnostics

1,016 works74,595 citations

Rebecca T. Hahn · Cardiac Valve Diseases and Treatments

833 works67,342 citations

Lawrence G. Lenke · Scoliosis diagnosis and treatment

1,198 works57,399 citations

What are the most-cited papers on NewYork–Presbyterian Hospital?

ScholarIQmost cited works

Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery

Martin B. Leon, Craig R. Smith, Michael J. Mack, D. Craig Miller, Jeffrey W. Moses, Lars G. Svensson, E. Murat Tuzcu, John G. Webb, Gregory P. Fontana, Raj Makkar, David L. Brown, Peter C. Block, Robert A. Guyton, Augusto D. Pichard, Joseph E. Bavaria, Howard C. Herrmann, Pamela S. Douglas, John L. Petersen, Jodi J. Akin, William N. Anderson, Duolao Wang, Stuart Pocock

New England Journal of Medicine. 20107,208 CitationsOPEN ACCESS

Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients

Craig R. Smith, Martin B. Leon, Michael J. Mack, D. Craig Miller, Jeffrey W. Moses, Lars G. Svensson, E. Murat Tuzcu, John G. Webb, Gregory P. Fontana, Raj Makkar, Mathew Williams, Todd Dewey, Samir Kapadia, Vasilis Babaliaros, Vinod H. Thourani, Paul J. Corso, Augusto D. Pichard, Joseph E. Bavaria, Howard C. Herrmann, Jodi J. Akin, William N. Anderson, Duolao Wang, Stuart Pocock

New England Journal of Medicine. 20116,358 CitationsOPEN ACCESS

Clinical End Points in Coronary Stent Trials

Donald E. Cutlip, Stephan Windecker, Roxana Mehran, Ashley B. Boam, David J. Cohen, Gerrit‐Anne van Es, Philippe Gabríel Steg, Marie‐Angèle Morel, Laura Mauri, Pascal Vranckx, Eugène McFadden, Alexandra J. Lansky, Martial Hamon, Mitchell W. Krucoff, Patrick W. Serruys

Circulation. 20075,430 Citations

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen, Stevo Julius, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Hans Ibsen, Krister Kristiansson, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel

The Lancet. 20025,421 Citations

Post-acute COVID-19 syndrome

Ani Nalbandian, Kartik Sehgal, Aakriti Gupta, Mahesh V. Madhavan, Claire McGroder, Jacob S. Stevens, Joshua R. Cook, Anna S. Nordvig, Daniel Shalev, Tejasav S. Sehrawat, Neha Ahluwalia, Behnood Bikdeli, Donald Dietz, Caroline Der‐Nigoghossian, Nadia Liyanage-Don, Gregg Rosner, Elana J. Bernstein, Sumit Mohan, Akinpelumi Beckley, David S. Seres, Toni K. Choueiri, Nir Uriel, John C. Ausiello, Domenico Accili, Daniel E. Freedberg, Matthew R. Baldwin, Allan Schwartz, Daniel Brodie, Christine Kim Garcia, Mitchell S.V. Elkind, Jean M. Connors, John P. Bilezikian, Donald W. Landry, Elaine Y. Wan

Nature Medicine. 20215,067 CitationsOPEN ACCESS

How much of the research on NewYork–Presbyterian Hospital is open access?

ScholarIQopen access share

67%OPEN ACCESS

Gold

Green

17%

Hybrid

Bronze

50%

Closed

33%